Abstract:Oxidative stress and mitochondrial damage play an important role in the pathology of cardiomyocytes apoptosis. However, the effects of Astragaloside IV(As-IV) on mitochondrial function have not been uncertain. Therefore, we assumed that As-IV inhibits hydrogen peroxide-induced apoptosis in H9c2 cells by attenuating oxidative stress and mitochondrial damage. To investigate the effects and mechanisms of As-IV on hydrogen peroxide-induced apoptosis in H9c2 cells. H9c2 cells were divided into three groups, including normal control group (cultured without intervention), hydrogen peroxidegroup (cultured with 200 μmol/L hydrogen peroxide for 2 hours), As-IV group (cultured with 100 μmol/L As-IV for 1 hour), As-IV with hydrogen peroxide group (pretreated with 100 μmol/L As-IV for 1 hour, then incubated with hydrogen peroxide for 2 hours). FITC/PI and DCFH-DA are stained to examine levels of apoptosis and ROS receptively. Levels of SOD and MDA were measured. Stained with JC-1 probe to observe the change of mitochondrial membrane potential (MMP). Western-blot was detected to analyze the expression of Drp-1. The apoptosis rate of hydrogen peroxide group ((13.22 ± 3.17 vs 40.55 ± 13.74)%, P < 0.05) was significantly higher than that of control group, which was lower in As-IV with hydrogen peroxide group((23.43 ± 4.3 vs 40.55 ± 13.74) %, P < 0.05). 2. The ROS levels were higher in hydrogen peroxide group than control group((73.53 ± 5.33 vs 39.02 ± 7.90) %, P < 0.05), which were significant reduced in As-IV with hydrogen peroxide group((57.6 ± 4.63 vs 73.53 ± 5.33) %, P < 0.05) Meanwhile, the activity of MDA was increased and the activity of SOD was decreased in hydrogen peroxide group compared with that in control group((10.97 ± 0.56 vs 4.85 ± 0.55) nmol/mL, P < 0.05), ((1192.23 ± 341.59 vs 2710.95 ± 274.32)U/L, P < 0.05). Compared with hydrogen peroxide group, As-IV with hydrogen peroxide group significantly decrease the activity of MDA and increase the activity of SOD ((6.58 ± 0.79 vs 10.97 ± 0.56) nmol/mL, P < 0.05), ((1984.66 ± 188.81 vs 1192.23 ± 341.59) U/L, P < 0.05). 3. MMP was lower and the expression of Drp1 was higher in hydrogen peroxide group than that in control group ((0.31 ± 0.01 vs 1.52 ± 0.25) %, P < 0.05), ((0.86 ± 0.003 vs 0.45 ± 0.004) %, P < 0.05). Compared with hydrogen peroxide group, MMP was significantly increased and the expression of Drp1 was downregulated ((0.65 ± 0.38 vs 0.31 ± 0.01) %, P < 0.05), ((0.72 ± 0.005 vs 0.86 ± 0.003) %, P < 0.05). As-IV exerts protective effects on hydrogen peroxide-induced apoptosis by attenuating oxidative stress and mitochondrial damage.

Astragaloside Iv Rescues Mpp+-Induced Mitochondrial Dysfunction Through Upregulation of Methionine Sulfoxide Reductase A

Astragaloside IV prevents MPP+-induced SH-SY5Y cell death via the inhibition of Bax-mediated pathways and ROS production

A Newly Synthesized Rhamnoside Derivative Alleviates Alzheimer's Amyloid-β-Induced Oxidative Stress, Mitochondrial Dysfunction, and Cell Senescence Through Upregulating SIRT3.

Astragaloside IV alleviates senescence of vascular smooth muscle cells through activating Parkin-mediated mitophagy

Astragaloside IV Ameliorates Motor Deficits and Dopaminergic Neuron Degeneration Via Inhibiting Neuroinflammation and Oxidative Stress in a Parkinson's Disease Mouse Model.

Integrative transcriptomics and proteomics analysis reveal the protection of Astragaloside IV against myocardial fibrosis by regulating senescence

Protection of Astragaloside Derivate on Oxidative Stress and Hypertrophy in Cardiomyocytes

Astragaloside IV Ameliorates Radiation-Induced Senescence Via Antioxidative Mechanism

Beneficial effects of astragaloside IV against angiotensin II-induced mitochondrial dysfunction in rat vascular smooth muscle cells

Phenylsulfate-induced oxidative stress and mitochondrial dysfunction in podocytes are ameliorated by Astragaloside IV activation of the SIRT1/PGC1α /Nrf1 signaling pathway

Astragaloside IV Protects 6-Hydroxydopamine-Induced SH-SY5Y Cell Model of Parkinson’s Disease via Activating the JAK2/STAT3 Pathway

Astragaloside IV protects against autoimmune myasthenia gravis in rats via regulation of mitophagy and apoptosis

Astragaloside IV Alleviates Infarction Induced Cardiomyocyte Injury by Improving Mitochondrial Morphology and Function

Methionine sulfoxide reductase A protects dopaminergic cells from Parkinson's disease-related insults

Astragaloside IV Inhibits Rotenone-Induced α-syn Presentation and the CD4 T-Cell Immune Response

Astragaloside IV promotes cerebral tissue restoration through activating AMPK- mediated microglia polarization in ischemic stroke rats

Astragaloside IV Ameliorates Cognitive Impairment and Protects Oligodendrocytes from Antioxidative Stress Via Regulation of the SIRT1/Nrf2 Signaling Pathway

Astragaloside IV protects against retinal iron overload toxicity through iron regulation and the inhibition of MAPKs and NF-B activation

Asiaticoside: attenuation of neurotoxicity induced by MPTP in a rat model of Parkinsonism via maintaining redox balance and up-regulating the ratio of Bcl-2/Bax.

PINK1/Parkin Pathway-Mediated Mitophagy by AS-IV to Explore the Molecular Mechanism of Muscle Cell Damage.

PS-B12-9: ASTRAGALOSIDE IV INHIBITS HYDROGEN PEROXIDE-INDUCED APOPTOSIS IN H9C2 CELLS BY ATTENUATING OXIDATIVE STRESS AND MITOCHONDRIAL DAMAGE